Jaguar Health Inc Share Price Today: Live Updates & Key Insights

Jaguar Health Inc share price today is $0.42, up 0.33%. The stock opened at $0.404 against the previous close of $0.418, with an intraday high of $0.4224 and low of $0.3986.

Jaguar Health Inc Share Price Chart

Jaguar Health Inc

us-stock
To Invest in {{usstockname}}
us-stock

Jaguar Health Inc Share Price Performance

$0.42 0.0033(0.33%) JAGX at 23 Mar 2026 01:45 PM Biotechnology
Lowest Today 0.3986
Highest Today 0.4224
Today’s Open 0.404
Prev. Close 0.418
52 Week High 15.48
52 Week Low 0.40
Day’s Range: Low 0.3986 High 0.4224
52-Week Range: Low 0.40 High 15.48
1 day return -
1 Week return -17.96
1 month return -30.59
3 month return -65.54
6 month return -79.9
1 year return -92.61
3 year return -99.14
5 year return -99.99
10 year return -

Jaguar Health Inc Institutional Holdings

DRW Securities, LLC 0.81

Geode Capital Management, LLC 0.21

Fidelity Extended Market Index 0.19

Tower Research Capital LLC 0.03

Spartan Total Market Index Pool G 0.01

Royal Bank of Canada 0.01

Fidelity Total Market Index 0.01

Fidelity Series Total Market Index 0.01

SBI Securities Co Ltd 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

LEONTEQ SECURITIES AG 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

Bank of America Corp 0.00

Morgan Stanley - Brokerage Accounts 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

BlackRock Inc 0.00

UBS Group AG 0.00

Jaguar Health Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Jaguar Health Inc Fundamentals

Market Cap 4.71 M

PB Ratio 1.4655

PE Ratio 0.0

Enterprise Value 35.46 M

Total Assets 53.43 M

Volume 335076

Jaguar Health Inc Company Financials

Annual Revenue FY23:10721000 10.7M, FY22:11956000 12.0M, FY21:4335000 4.3M, FY20:9385000 9.4M, FY19:5775257 5.8M

Annual Profit FY23:8876000 8.9M, FY22:9937000 9.9M, FY21:2002000 2.0M, FY20:6105000 6.1M, FY19:1959445 2.0M

Annual Net worth FY23:-39711000 -39.7M, FY22:-47454000 -47.5M, FY21:-60251000 -60.3M, FY20:-36791000 -36.8M, FY19:-38539436 -38.5M

Quarterly Revenue Q3/2025:3083000 3.1M, Q2/2025:2979000 3.0M, Q1/2025:2214000 2.2M, Q3/2024:3108000 3.1M, Q2/2024:2721000 2.7M

Quarterly Profit Q3/2025:1991000 2.0M, Q2/2025:2452000 2.5M, Q1/2025:1699000 1.7M, Q3/2024:2567000 2.6M, Q2/2024:2294000 2.3M

Quarterly Net worth Q3/2025:-9502000 -9.5M, Q2/2025:-10407000 -10.4M, Q1/2025:-10464000 -10.5M, Q3/2024:-9854000 -9.9M, Q2/2024:-9492000 -9.5M

About Jaguar Health Inc & investment objective

Company Information Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.

Organisation Biotechnology

Employees 49

Industry Biotechnology

CEO Ms. Lisa A. Conte

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Jaguar Health Inc FAQs

What is the share price of Jaguar Health Inc today?

The current share price of Jaguar Health Inc is $0.42.

Can I buy Jaguar Health Inc shares in India?

Yes, Indian investors can buy Jaguar Health Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Jaguar Health Inc shares in India?

You can easily invest in Jaguar Health Inc shares from India by:

Can I buy fractional shares of Jaguar Health Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Jaguar Health Inc?

Jaguar Health Inc has a market cap of $4.71 M.

In which sector does Jaguar Health Inc belong?

Jaguar Health Inc operates in the Biotechnology sector.

What documents are required to invest in Jaguar Health Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Jaguar Health Inc?

The PE ratio of Jaguar Health Inc is N/A and the PB ratio is 1.47.